Ramucirumab

Product Name: Ramucirumab
CAS No.: 947687-13-0
Chemical Name: Ramucirumab
Synonyms: Cyramza;LY3009806;IMC-1121B;Ramucirumab;Ramucirumab (anti-VEGFR2);Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
CBNumber: CB72738188
Formula Weight: 0
MOL File: Mol file

More

Less

Ramucirumab Property

storage temp.: Store at -20°C
solubility: Soluble in DMSO
form: Liquid
color: Colorless to light yellow

More

Less

Safety

Hazardous Substances Data: 947687-13-0(Hazardous Substances Data)

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

ChemScene

Product number: CS-0031056
Product name: Ramucirumab
Packaging: 1mg
Price: $400
Updated: 2021/12/16

Biosynth Carbosynth

Product number: FR159043
Product name: Ramucirumab
Packaging: 1mg
Price: $425
Updated: 2021/12/16

American Custom Chemicals Corporation

Product number: ATB0023429
Product name: RAMUCIRUMAB
Purity: 95.00%
Packaging: 5MG
Price: $498.75
Updated: 2021/12/16

Biosynth Carbosynth

Product number: FR159043
Product name: Ramucirumab
Packaging: 2mg
Price: $650
Updated: 2021/12/16

Biosynth Carbosynth

Product number: FR159043
Product name: Ramucirumab
Packaging: 25mg
Price: $2150
Updated: 2021/12/16

More

Less

Ramucirumab Chemical Properties,Usage,Production

Clinical Use

Human monoclonal antibody:
Treatment of advanced gastric cancer or gastrooesophageal junction adenocarcinoma, colorectal cancer and non-small cell lung cancer (NSLC)

target

VEGFR2

Drug interactions

Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live vaccines - avoid.

Metabolism

The metabolism of ramucirumab has not been studied. Monoclonal antibodies are mainly cleared by catabolism.

Ramucirumab Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Ramucirumab Suppliers

China 68 India 2 United Kingdom 1 United States 6 Global 77

Wuhan Fortuna Chemical Co., Ltd

Tel: 027-59207852 13308628970
Fax: QQ3130921841
Email: buy@fortunachem.com
Country: China
ProdList: 2871
Advantage: 58

Dalian Meilun Biotech Co., Ltd.

Tel: 0411-62910999 13889544652
Email: meilunui@163.com
Country: China
ProdList: 4727
Advantage: 58

Nanjing Sunlida Biological Technology Co., Ltd.

Tel: 025-57798810
Fax: 025-57019371
Email: sales@sunlidabio.com
Country: China
ProdList: 3239
Advantage: 55

Sichuan Wei Keqi Biological Technology Co., Ltd.

Tel: 028-81700200 18116577057
Fax: 028-81705658
Email: 3003855609@qq.com
Country: China
ProdList: 7887
Advantage: 56

Taizhou KEDE Chemical Co., Ltd

Tel: 0576-84613060 13093829633
Fax: 0576-84613060
Email: sales@kedechemical.com
Country: China
ProdList: 298
Advantage: 60

Shanghai Lollane Biological Technology Co.,Ltd.

Tel: 021-52996696，15000506266 15000506266
Fax: +86-21-52996696
Country: China
ProdList: 4512
Advantage: 55

Intelligence Pharm Science(Shanghai) Co., Ltd.

Tel: 021-57898186
Fax: 021-37699262
Country: China
ProdList: 449
Advantage: 55

Creative Peptides

Tel
Email: info@creative-peptides.com
Country: United States
ProdList: 6083
Advantage: 56

Shanghai Hanjing Chemicals Co., Ltd.

Tel: 021-54285032 13641685631
Fax: +86 (21) 5443 7651
Email: gerry.shu@hanjingchemicals.com
Country: China
ProdList: 76
Advantage: 55

Shanghai EFE Biological Technology Co., Ltd.

Tel: 021-65675885 18964387627
Fax: 021-65675885
Email: info@efebio.com
Country: China
ProdList: 9806
Advantage: 58

947687-13-0, RamucirumabRelated Search:

Adalimumab Ustekinumab Nivolumab Bevacizumab Daratumumab OMALIZUMAB Lambrolizumab Dulaglutide Infliximab Rituximab palivizumab Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer Atezolizumab Denosumab CETUXIMAB Evolocumab ipilimumab Eculizumab

Ramucirumab

Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor

Cyramza

IMC-1121B

LY3009806

Ramucirumab (anti-VEGFR2)

947687-13-0